-
AELIP took part in the IV International Laminopathy Meeting -
On May 11th, the International Association of Relatives and Affected of Lipodystrophies (AELIP) participated in the International Congress of Laminopathies.The event took place from ...
News
-
AELIP meets with Costa Rican Health Professionals at the 10th ALIBER Ibero-American Meeting on Rare Diseases -
The International Association of Families and People Affected by Lipodystrophies AELIP took advantage of the framework of the 10th A ...
-
AELIP participates in Costa Rica in the High Level Forum - X Ibero-American Meeting on Rare Diseases ALIBER -
The International Association of Lipodystrophy Families and Patients (AELIP) is participating on 9 and 10 February in Costa Rica in t ...
-
AELIP participated in Porto in the meeting of the Lipodystrophy Group organised by the Portuguese Society of Endocrinology, Diabetes and Metabolism. -
The International Association of Relatives and Affected of Lipodystrophies AELIP, participat ...
-
ECLIP 2023 will be held in Pisa (Italy) next 28th and 29th September. -
The International Association of Families and People Affected by Lipodystrophies AELIP , will be present next 28th and 29th September in Pisa (Italy) where the annual meet ...
-
AELIP is already working on its work plan for 2023 -
AELIP is working on the next lines of action of the International Association of Lipodystrophies Affected and Relatives, included in the Work Plan 2023. AELIP focuses its efforts on eleven d ...
-
AELIP PARTICIPATES IN THE DEVELOPMENT OF THE LIPO-DDx® APP CREATED BY PROF. DAVID ARAÚJO- VILAR -
LIPO-DDx® is a mobile application based on a personal algorithm developed by Prof. David Araújo-Vilar. With the support of the University of Sant ...
-
AELIP opens the registration period for its 10th INTERNATIONAL SYMPOSIUM ON LIPODYSTROPHY -
The Asociación de Familiares y Afectados de Lipodistrofias (AELIP), will celebrate the tenth edition of the 'SIMPOSIUM INTERNACIONAL DE LIPODISTROFIAS' ...
-
Pathogenic mechanism of acquired generalised lipodystrophy described -
Researchers from the U754 CIBERER led by María Teresa Caballero at the Hospital La Paz-IdiPAZ have described the pathogenic mechanism by which autoantibodies directed again ...
-
"The Interministerial Commission on Drug Pricing proposes NOT to accept the allegations and not to include Metreleptin in the NHS". -
Aelip ends the year with sad news for all people affected by Lipodystrophy as well as for their families and ...